Patriot One (TSX: $PAT.TO) (OTCQX:
$PTOTF) @patriot1tech Reports Subsidiary Xtract #AI division reports new project contract with Canexia Health;
#Artificialintelligence
Project ACTT (Access to Cancer Testing & Treatment in Response to
COVID-19) aims to provide a liquid biopsy solution, that requires only a simple
blood draw, as an alternative to surgical tissue biopsies
VANCOUVER, BC –
JULY 16, 2020 – Investorideas.com Newswire and Homelanddefensestocks.com –Security/Covid -19/AI stock news -Patriot
One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF), (FRANKFURT:
0PL) wholly-owned subsidiary Xtract
Technologies Inc. (“Xtract AI”) is pleased to announce a new project contract
with Canexia Health (formerly Contextual Genomics) and supported by the Digital
Technology Supercluster.
Read this news featuring Patriot One in full at https://www.investorideas.com/news/2020/defense/07161PatriotOne-CanexiaHealth.asp
As the
COVID-19 pandemic has impacted many areas of life, including the diagnosis and
treatment of other health conditions, people have chosen to forgo care in
attempts to minimize their potential exposure to the Coronavirus. Cancer
patients are twice as likely to contract COVID-19, and three times as likely to
die from it, compared to the general population. However, by avoiding time
spent in medical facilities to limit exposure to the virus, patients are
delaying treatment and their disease may spread further. At least 100,000
surgeries in Canada, including cancer tissue biopsies, have been delayed or
postponed since early March because of COVID-19.
Project ACTT
(Access to Cancer Testing & Treatment in Response to COVID-19) aims to
provide a liquid biopsy solution, that requires only a simple blood draw, as an
alternative to surgical tissue biopsies. This minimally invasive DNA test,
which can be delivered remotely, will then be analyzed by artificial
intelligence technology to identify circulating tumor DNA (ctDNA) in plasma,
and matches patients with targeted treatments shown to improve outcomes. Not
only will this reduce a patient’s need to attend medical facilities, it will
also increase health system capacity for those with recurrent or metastatic
lung, breast, or colon cancer.
Other
partners in the project include AstraZeneca Canada, Queen’s University, the
Eastern Ontario Regional Laboratory Association, Genolife, emtelligent,
Novateur, Semaphore Solutions and Illumina. Xtract AI will develop, train, and
deploy Natural Language Processing (NLP) models to assist in the
management, understanding, and integration of semi-structured information from
a mutation and cancer-type database.
Martin
Cronin, Patriot One Technologies CEO, said “knowing how far reaching the
effects of COVID-19 are, we’re delighted to be involved in another project
utilizing artificial intelligence, and our team’s expertise, in an effort to
significantly, and hopefully positively, impact the lives of cancer patients.”
About XTRACT TECHNOLOGIES INC - a
subsidiary of Patriot One Technologies Inc.
Xtract
AI develops and commercializes artificial intelligence, machine learning, deep
neural networks and predictive solutions utilizing advanced technology for
public institutions and private enterprise. The firm has an award
winning, highly skilled team that develops AI solutions to solve challenges across computer vision
(CV), natural language processing (NLP), anomaly detection, and time-series
analysis for applications ranging from security and defence to environmental
solutions and healthcare. For more information on building your AI solution,
visit: xtract.ai
About Patriot
One Technologies Inc. (TSX:PAT) (OTCQX: PTOTF) (FRA: 0PL):
Patriot Ones' mission is to deliver innovative threat
detection and counter-terrorism solutions for safer communities. Our PATSCAN™
Multi-Sensor Covert Threat Detection Platform provides a network of advanced
sensor technologies with powerful next generation AI/machine learning software.
The network can be covertly deployed from far perimeter to interiors across
multiple weapons-restricted facilities. The PATSCAN™ platform identifies and
reports threats wherever required; car park, building approach, employee &
public entryways and inside the facilities. Each solution in the platform
identifies weapons, related threats or disturbances, or potential health and
safety threats for immediate security response. Our motto Deter, Detect and
Defend is based on the belief that widespread use of the PATSCAN™ platform will
act as an effective deterrent to diminish the epidemic of active threats around
the globe. For more information, visit: www.patriot1tech.com or follow us
on Twitter and Facebook.
About Digital Technology
Supercluster:
The Digital Technology Supercluster solves some of industry’s and society’s biggest problems
through Canadian-made technologies. We bring together private and public sector
organizations of all sizes to address challenges facing Canada’s economic
sectors including healthcare, natural resources, manufacturing, and
transportation. Through this ‘collaborative innovation,’ the Supercluster helps
to drive solutions better than any single organization could on its own.
The Digital Technology Supercluster is led by industry leaders such as D-Wave, LifeLabs, LlamaZOO, Lululemon, MDA, Microsoft, Mosaic Forest Management, Sanctuary AI, Teck Resources Limited, TELUS, Terramera, and 1Qbit. Together, we
work to position Canada as a global hub for digital innovation. A full list of
Members can be found here.
About
the COVID-19 Program:
The COVID-19 Program aims to improve the health and safety of
Canadians and support Canada’s ability to address issues created by the
COVID-19 outbreak. In addition, the program will build expertise and capacity
to anticipate and address issues that may arise in future health crises, from
healthcare to a return to work and community. More information can be found here.
For further information, please contact:
Media Contacts
Scott Ledingham, Patriot One Technologies
+1-613-806-7135
scott@prmedianow.com
Scott Ledingham, Patriot One Technologies
+1-613-806-7135
scott@prmedianow.com
For Digital Technology Supercluster Inquiries
Elysa Darling, Switchboard PR
1-587-890-9833
elysa@switchboardpr.com
CAUTIONARY DISCLAIMER STATEMENT:
No
securities exchange has reviewed nor accepts responsibility for the adequacy or
accuracy of the content of this news release. This news release contains
forward-looking statements relating to system sales, product development,
licensing, commercialization and regulatory compliance issues and other
statements that are not historical facts. Forward-looking statements are often
identified by terms such as "will", "may",
"should", "anticipate", "expects”,” believes”, and
similar expressions. All statements other than statements of historical fact,
included in this release are forward-looking statements that involve risks and
uncertainties. There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ materially from
those anticipated in such statements. Important factors that could cause actual
results to differ materially from the Company's expectations include
counterparty default and other risks detailed from time to time in the filings
made by the Company with securities regulations. The reader is cautioned that
assumptions used in the preparation of any forward-looking information may
prove to be incorrect. Events or circumstances may cause actual results to
differ materially from those predicted, as a result of numerous known and
unknown risks, uncertainties, and other factors, many of which are beyond the
control of the Company. The reader is cautioned not to place undue reliance on
any forward-looking information. Such information, although considered
reasonable by management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly
qualified by this cautionary statement. The forward-looking statements
contained in this news release are made as of the date of this news release and
the Company will update or revise publicly any of the included forward-looking
statements only as expressly required by applicable law.
Neither
the Toronto Stock Exchange (TSX) nor its Regulation Services Provider (as that
term is defined in policies of the TSX) accepts responsibility for the adequacy
or accuracy of this release.
Paid
News -Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure : this news release featuring TSX: PAT is a paid for news
release on Investorideas.com ($750) More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Please
read Investorideas.com privacy policy:
About
Investorideas.com
Sign up for free
stock news alerts at Investorideas.com
